IP Verse

Strawman competitive analysis

Loading summary...

Explore patent oppositions filed by Strawman against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 6, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3793613	Immunoconjugates	BOLT BIOTHERAPEUTICS	Sep 30, 2025
EP3220926	Engineered Gamma Delta T-Cells	ADICET BIO	Sep 25, 2025
EP3847206	Method Of Producing Lignin With Reduced Amount Of Odorous Substances	VALMET	Sep 23, 2025
EP3073964	Cuff Stitching Reinforcement	ST JUDE MEDICAL	Sep 18, 2025
EP3611258	System And Method For Genome Editing	INSTITUTE OF ZOOLOGY	Sep 11, 2025
EP4096717	Treatment Of Cancer	INNATE PHARMA	Sep 11, 2025
EP3960072	Compact On-Body Physiological Monitoring Devices And Methods Thereof	ABBOTT	Sep 10, 2025
EP3359572	Method For Treating Multiple Sclerosis	F HOFFMANN LA ROCHE	Aug 27, 2025
EP3526321	Use Of Tonicifying Agents To Enhance Recombinant Adeno-Associated Virus Yield	DIMENSION THERAPEUTICS	Aug 27, 2025
EP3541951	Non-Unique Barcodes In A Genotyping Assay	PERSONAL GENOME DIAGNOSTICS	Aug 20, 2025

Discover the latest PTAB cases involving Strawman, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Strawman with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 6, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
STRAWMAN	339	-	-	-
AMGEN	8	138	8	11
CHUGAI SEIYAKU KABUSHIKI KAISHA	3	78	-	1
NOVARTIS	6	422	-	21